[HTML][HTML] The world federation of ADHD international consensus statement: 208 evidence-based conclusions about the disorder

SV Faraone, T Banaschewski, D Coghill… - Neuroscience & …, 2021 - Elsevier
Background Misconceptions about ADHD stigmatize affected people, reduce credibility of
providers, and prevent/delay treatment. To challenge misconceptions, we curated findings …

[HTML][HTML] Live fast, die young? A review on the developmental trajectories of ADHD across the lifespan

B Franke, G Michelini, P Asherson… - European …, 2018 - Elsevier
Attention-deficit/hyperactivity disorder (ADHD) is highly heritable and the most common
neurodevelopmental disorder in childhood. In recent decades, it has been appreciated that …

ADHD in children and young people: prevalence, care pathways, and service provision

K Sayal, V Prasad, D Daley, T Ford, D Coghill - The lancet psychiatry, 2018 - thelancet.com
Attention-deficit hyperactivity disorder (ADHD) is a common childhood behavioural disorder.
Systematic reviews indicate that the community prevalence globally is between 2% and 7 …

[HTML][HTML] The management of ADHD in children and adolescents: bringing evidence to the clinic: perspective from the European ADHD Guidelines Group (EAGG)

D Coghill, T Banaschewski, S Cortese… - European child & …, 2021 - Springer
ADHD is the most common neurodevelopmental disorder presenting to child and adolescent
mental health, paediatric, and primary care services. Timely and effective interventions to …

Treatment strategies for ADHD: an evidence-based guide to select optimal treatment

A Caye, JM Swanson, D Coghill, LA Rohde - Molecular psychiatry, 2019 - nature.com
Attention-deficit/hyperactivity disorder (ADHD) is a common and impairing disorder affecting
children, adolescents, and adults. Several treatment strategies are available that can …

A literature review and meta-analysis on the effects of ADHD medications on functional outcomes

H Boland, M DiSalvo, R Fried, KY Woodworth… - Journal of Psychiatric …, 2020 - Elsevier
Objective To conduct a systematic review and meta-analysis of literature from large
databases and registries to assess the effects of ADHD medication on associated functional …

Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents–assessment of adverse events in non‐randomised studies

OJ Storebø, N Pedersen, E Ramstad… - Cochrane Database …, 2018 - cochranelibrary.com
Background Attention deficit hyperactivity disorder (ADHD) is a common
neurodevelopmental disorder in childhood. The psychostimulant methylphenidate is the …

[HTML][HTML] Attention-deficit/hyperactivity disorder: a current overview

T Banaschewski, K Becker, M Döpfner… - Deutsches Ärzteblatt …, 2017 - ncbi.nlm.nih.gov
Background Attention-deficit/hyperactivity disorder (ADHD) is a common, early-onset,
persistent developmental disorder of childhood and adolescence, with a prevalence of …

Prevention of dabigatran-related gastrointestinal bleeding with gastroprotective agents: a population-based study

EW Chan, WCY Lau, WK Leung, MTC Mok, Y He… - Gastroenterology, 2015 - Elsevier
Background & Aims Use of dabigatran, an inhibitor of thrombin, increases the risk of
gastrointestinal bleeding (GIB). However, it is not clear whether gastroprotective agents …

ADHD medication and substance-related problems

PD Quinn, Z Chang, K Hur… - American journal of …, 2017 - Am Psychiatric Assoc
Objective: Substance use disorders are major contributors to excess mortality among
individuals with attention deficit hyperactivity disorder (ADHD), yet associations between …